1. An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer
    Narges Dastmalchi et al, 2021, Expert Review of Molecular Diagnostics CrossRef
  2. Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
    L. E. Anselmino et al, 2021, Scientific Reports CrossRef
  3. Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
    Qitong Wu et al, 2021, Cancers CrossRef
  4. Ribosome Proteins Represented by RPL27A Mark the Development and Metastasis of Triple-Negative Breast Cancer in Mouse and Human
    Weipeng Zhao et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  5. A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers
    Shunjie Zhang et al, 2021, Analytica Chimica Acta CrossRef
  6. PRMT1 Confers Resistance to Olaparib via Modulating MYC Signaling in Triple-Negative Breast Cancer
    Wen-Jing Hsu et al, 2021, Journal of Personalized Medicine CrossRef
  7. NIR Fluorescent Imaging and Photodynamic Therapy with a Novel Theranostic Phospholipid Probe for Triple-Negative Breast Cancer Cells
    Natalia I. Rubtsova et al, 2021, Bioconjugate Chemistry CrossRef
  8. Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
    Dey Nandini et al, 2021, Pharmaceuticals CrossRef